Search

By engaging with the barbershop community, researchers aim to destigmatize HIV care services and improve HIV prevention in a trusted and culturally relevant setting. About 1.1 million people are living with HIV in the United States. After years of decline in the number of new HIV cases, that trend has slowed, with the number of...

In the phase 2b ARROYO trial, although blood eosinophils were almost completely depleted, benralizumab treatment did not show any therapeutic advantage compared to a placebo for the treatment of chronic spontaneous urticaria. Chronic spontaneous urticaria (CSU) involves a complex interplay of various cell types and molecular mechanisms, with mast cells traditionally considered the primary drivers....

In this MD Newsline exclusive interview, internist/HIV specialist Dr. Pete Thomas sits down for an interview with resident physician/public health professional Dr. Janelle Hadley to discuss how social determinants of health contribute to HIV prevalence and outcomes in the Black community. Dr. Janelle Hadley: What social determinants of health contribute to HIV prevalence and outcomes in...

Today, the U.S. Department of Health and Human Services and the U.S. Public Health Service (USPHS) published an updated solid organ transplant guideline to assess donors and monitor recipients for human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus infections. This guideline reflects advances in transplant technology and safety that can increase the number of...

Heterosexual Black people are twenty times more likely to be diagnosed with HIV than heterosexual White people. The rates of HIV among individuals who practice homosexual sex are well-studied. However, there are limited studies on the prevalence of HIV among heterosexual individuals, which this study aimed to address. In this study, the prevalence of HIV...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Sept. 22, 2023 Dolutegravir produces more frequent viral suppression during delivery than current antiretroviral therapy regimens, including raltegravir and atazanavir-ritonavir. The medical literature contains limited data on the safety and efficacy of dolutegravir antiretroviral therapy (ART) versus current therapy regimens for managing human immunodeficiency virus type 1...

This study on gay and bisexual men in Australia shows that while COVID-19 outbreak-related measures led to fewer sexual partners, there was a decline in condom and pre-exposure prophylaxis use. COVID-19 has not just caused significant mortality, but it has also disrupted the healthcare system, including the delivery of care for existing conditions like HIV,...

In this MD Newsline exclusive interview, internist/HIV specialist Dr. Pete Thomas sits down for an interview with resident physician/public health professional Dr. Janelle Hadley to discuss PrEP and shared decision making in HIV prevention. Dr. Janelle Hadley: What role does PrEP play in your practice for HIV prevention? Dr. Pete Thomas: “So the good thing is...

Researchers explored the intricate relationship between HIV infection in Ethiopian women and the development of precancerous cervical lesions, addressing existing inconsistencies in the literature, with the goal of determining the true impact of HIV on the risk of precancerous cervical lesions in this population. Some studies hint at a significant link between HIV and pre-cancerous...

In this MD Newsline exclusive interview, internist/HIV specialist Dr. Pete Thomas sits down for an interview with resident physician/public health professional Dr. Janelle Hadley to discuss HIV treatment over the years and the HIV care continuum. Dr. Janelle Hadley: Can you speak on how HIV treatment has changed over the years? Dr. Pete Thomas: “When I...